🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Randomized, Multicenter, Double-Masked, Saline-Controlled Trial to Evalua...
Status
Active Not Recruiting
Location
Site 101
Start Date
2024-07-31
Trial ID
NCT06565650
Assess the impact of concomitant Miebo use while wearing contact lenses...
Status
Completed
Location
Site 101
Start Date
2025-07-02
Trial ID
NCT07054606
Treatments Being Tested
Miebo (Perfluorohexyloctane) is a novel, non-aqueous, single entity, preser...
Status
Completed
Location
Gordon Schanzlin New Vision Institute
Start Date
2023-09-21
Trial ID
NCT06176651
Treatments Being Tested
This PMCF study is carried out following successful CE marking of NovaTears...
Status
Completed
Location
NTO-001 Investigational Site
Start Date
2020-11-09
Trial ID
NCT04521465
Treatments Being Tested
The purpose of this study is to explore the tear lipid layer quantitatively...
Status
Completed
Location
The Ohio State University College of Optometry
Start Date
2022-03-27
Trial ID
NCT05288582
Treatments Being Tested
Patients with mild to moderate dry eye disease will be randomized to receiv...
Status
Completed
Location
Medical University of Vienna, Department of Clinical Pharmacology
Start Date
2016-12-15
Trial ID
NCT03048526
Treatments Being Tested
Lid wiper epitheliopathy (LWE) is a relatively new entry into the abundance...
Status
Completed
Location
Maitland Vision Center
Start Date
2024-05-27
Trial ID
NCT06671041
Treatments Being Tested
This study will evaluate the efficacy, safety and tolerability of perfluoro...
Status
Completed
Location
Investigational site
Start Date
2018-01-03
Trial ID
NCT03333057
Perfluorohexyloctane eye drops is the only drug in China approved for treat...
Status
Not Yet Recruiting
Location
Xiamen Eye Center Affiliated to Xiamen University
Start Date
2026-03-01
Trial ID
NCT07457021
This is a prospective, multicenter, open-label, randomized controlled trial...
Status
Not Yet Recruiting
Location
Beijing Anzhen Hospital
Start Date
2026-06-30
Trial ID
NCT07679685
Treatments Being Tested